Prices delayed by at least 15 minutes | Print


Valirx PLC (VAL)

ORD 0.1P
Sell: 3.5p|Buy: 3.6p|Change: 0.30 (-7.79%)

Open 

3.85p


Previous close 

3.85p


Trade high 

3.8p


Volume 

888,756


Year high 

15.00p


Year low 

3.46p


Dividend yield 

-


Market capitalisation 

£4.70 mn


P/E ratio 

-


ISIN 

GB00BLH13C52


This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment

Share price

Performance 27/03/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Valirx PLC 0.00
FTSE AIM All Share+ 0.35
More...

Company profile

ValiRx PLC is a UK-based biopharmaceutical company. It mainly engages in developing technologies and products in oncology therapeutics and diagnostics. The area of focus for the company is the treatment of cancer and associated biomarkers,specializing in epigenomic and genetic analysis. The company develops therapeutics across fields in oncology and has a portfolio of products in the pipeline which include GeneICE for Silencing Rebellious Genes, VAL201 for prostate cancer, NAV3 for the cancer screening test, and VAL401 for lung cancer.

Sector 

Healthcare


News

Recent trades

DateTimePriceQuantityValue (£)
28/03/202404:19:203.58520,000717.00
28/03/202404:15:523.5513,380474.99
28/03/202404:05:133.5536,0001,278.00
28/03/202404:02:183.50560,3402,114.92
28/03/202404:01:503.59250,0008,975.00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.